1. Home
  2. CRNX vs GDV Comparison

CRNX vs GDV Comparison

Compare CRNX & GDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRNX
  • GDV
  • Stock Information
  • Founded
  • CRNX 2008
  • GDV 2003
  • Country
  • CRNX United States
  • GDV United States
  • Employees
  • CRNX N/A
  • GDV N/A
  • Industry
  • CRNX Biotechnology: Pharmaceutical Preparations
  • GDV Investment Managers
  • Sector
  • CRNX Health Care
  • GDV Finance
  • Exchange
  • CRNX Nasdaq
  • GDV Nasdaq
  • Market Cap
  • CRNX 2.8B
  • GDV 2.4B
  • IPO Year
  • CRNX 2018
  • GDV N/A
  • Fundamental
  • Price
  • CRNX $39.96
  • GDV $26.62
  • Analyst Decision
  • CRNX Buy
  • GDV
  • Analyst Count
  • CRNX 12
  • GDV 0
  • Target Price
  • CRNX $74.45
  • GDV N/A
  • AVG Volume (30 Days)
  • CRNX 1.2M
  • GDV 186.0K
  • Earning Date
  • CRNX 11-06-2025
  • GDV 01-01-0001
  • Dividend Yield
  • CRNX N/A
  • GDV 5.81%
  • EPS Growth
  • CRNX N/A
  • GDV N/A
  • EPS
  • CRNX N/A
  • GDV N/A
  • Revenue
  • CRNX $1,392,000.00
  • GDV N/A
  • Revenue This Year
  • CRNX $405.68
  • GDV N/A
  • Revenue Next Year
  • CRNX $1,034.87
  • GDV N/A
  • P/E Ratio
  • CRNX N/A
  • GDV N/A
  • Revenue Growth
  • CRNX 0.51
  • GDV N/A
  • 52 Week Low
  • CRNX $24.10
  • GDV $18.04
  • 52 Week High
  • CRNX $62.53
  • GDV $23.00
  • Technical
  • Relative Strength Index (RSI)
  • CRNX 44.22
  • GDV 41.21
  • Support Level
  • CRNX $41.41
  • GDV $26.90
  • Resistance Level
  • CRNX $43.89
  • GDV $27.00
  • Average True Range (ATR)
  • CRNX 1.94
  • GDV 0.29
  • MACD
  • CRNX -0.41
  • GDV -0.05
  • Stochastic Oscillator
  • CRNX 17.99
  • GDV 2.06

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

About GDV Gabelli Dividend & Income Trust of Beneficial Interest

Gabelli Dividend & Income Trust operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of total return on its assets with an emphasis on dividends and income. To achieve its objective, the fund may invest its assets in dividend-paying securities or other income-producing securities. The fund invests in various sectors, in which Financial Services, Food and Beverage, Health Care, Consumer Products, Electronics, and Computer Software & Services and others.

Share on Social Networks: